1. British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (K.F.D., P.W., N.S., P.S.J., J.J.V.M.).
2. Division of Cardiac Surgery, St Michael’s Hospital, University of Toronto, Canada (S.V.).
3. Department of Cardiology, University Medical Center and University of Groningen, The Netherlands (R.A.D.B.).
4. Montreal Heart Institute, Université de Montréal, Canada (E.O.).
5. AstraZeneca R&D, Gothenburg, Sweden (O.B., A.H., A.M.L., D.L., D.J.L., M. Sjöstrand).
6. Rigshospitalet Copenhagen University Hospital, Denmark (L.K.).
7. Saint Luke’s Mid America Heart Institute and University of Missouri-Kansas City (M.N.K.).
8. George Institute for Global Health, University of New South Wales, Sydney, Australia (M.N.K.).
9. Wroclaw Medical University, Poland (P.P.).
10. TIMI (Thrombolysis in Myocardial Infarction) Study Group, Cardiovascular Division, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MA (M.S.S., D.A.M.).
11. Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark (M. Schou).
12. Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA (S.D.S.).